Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

HIV peptide-loaded dendritic cells evaluated in DALIA trial

March 15, 2012

PX'Therapeutics begins phase I trial of HIV vaccine

March 14, 2012

GM-CSF-adjuvanted vaccine provides long-term protection in HIV model

March 14, 2012

GeoVax obtains FDA approval to advance adjuvanted HIV vaccine to clinic

March 14, 2012

In vitro results show potency of novel bispecific HIV-1-neutralizing antibody

March 13, 2012

Dendritic cell-based vaccine is safe in patients with HIV

March 12, 2012

Recombinant protein therapy active against HIV in phase II trial

March 9, 2012

Gene-modified stem cell therapy shows promise to combat HIV infection

March 9, 2012

Fatty acid blocks HIV-1 infection in ex vivo cervical tissue model

March 8, 2012

Bristol-Myers Squibb divulges new products to treat HIV infection

March 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...